References
- 1. Săceleanu V. Neurochirurgie clinică. Sibiu: Editura Universității “Lucian Blaga” Sibiu; 2014.
- 2. Holleczek B, Zampella D, Urbschat S, Sahm F, von Deimling A, Oertel J et al. Incidence, mortality, and outcome of meningiomas: A population-based study from Germany. Cancer Epidemiology. 2019;62:101562.
- 3. Săceleanu V, Paz R, Garcia J, Rivero Y, Cindea CN, Cacciotti I, et al. Production of Synthetic Models for Neuro-oncology Training by Additive Manufacturing. Brain Sci. 2021;11, x.
- 4. Alruwaili AA, De Jesus O. Meningioma. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
- 5. Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko K et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016, Neuro-Oncology. 2019;v1–v100.
- 6. Lim YS, Kim MK, Park BJ, Kim TS, Lim YJ. Long Term Clinical Outcomes of Malignant Meningiomas. The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology. Seoul: Brain Tumor Res Treat.; 2013. Oct; 1(2): p. 85-90.
- 7. Wiemels J, Wrensch M, Claus E. Epidemiology and etiology of meningioma. J Neuro-oncology. 2010;Sep;99(3):307-14.
- 8. Louis DN, Perry A, Reifenberger G, vonDeimling A, Figarella-Branger D, Cavenee WK et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta neuropathologica. 2016;131(6):803-20.
- 9. Buerki RA, Horbisnky CM, Kruser T, Horowitz PM, James CD, Rimas VL. An overview of meningiomas. Future Oncology. 2018;14(21):2161-2177.
- 10. Huntoon K, Toland AMS, Dahiya S. Meningioma: A Review of Clinicopathological and Molecular Aspects. Front Oncology. 2020;10:579599.
- 11. Quddusi A, Shamim MS. Simpson grading as predictor of meningioma recurrence. J Pak Med Assoc. 2018;68(5):819-821.
- 12. Nanda A, Bir SC, Maiti TK, Konar SK, Missios S, Guthikonda B. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. J Neurosurg. 2017;126(1):201-211.
- 13. Gousias K, Schramm J, Simon M. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. J Neurosurg. 2016;125(3):551-60.
- 14. Bartek J Jr, Sjåvik K, Förander P, Solheim O, Gulati S, Weber C et al. 2. Predictors of severe complications in intracranial meningioma surgery: a population-based multicenter study. World Neurosurg. 2015;83(5):673-8.
- 15. Daraz B, Piela A. Treatment and prevention of EPH-gestosis. Pieleg Polozna. 1978;(5):7-8
- 16. Johnson JE, Fuller SS, Endress MP, Rice VH. Altering patients’ responses to surgery: an extension and replication. Research in nursing & health. 1978;1(3):111-21.
- 17. Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD et al. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro-oncology. 2014;16(11):1547-53.
- 18. Samblas J, Luis Lopez Guerra J, Bustos J, Angel Gutierrez-Diaz J, Wolski M, Peraza C et al. Stereotactic radiosurgery in patients with multiple intracranial meningiomas. J Buon. 2014;19(1):250-5.
- 19. Puchner MJ, Hans VH, Harati A, Lohmann F, Glas M, Herrlinger U. Bevacizumab-induced regression of anaplastic meningioma. Ann Oncol. 2010;21(12):2445-2446.
- 20. Aizer AA, Bi WL, Kandola MS, Lee EQ, Nayak L, Rinne ML et al. Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015;121(24):4376-81.